UBS
No price chart data available for 1D timeframe.
Rating
Why Price Moved
The stock is down amid renewed tensions between UB...
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
UBS Group AG, a financial services giant headquartered in Zurich, Switzerland, since its founding in 1862 (and known as UBS AG until its name change in December 2014), delivers a comprehensive range o...
Latest News
12 hours ago · prnewswire.com
TI CEO Haviv Ilan to speak at UBS investor conferenceDec. 1, 2026, 10:15 a.m. Mountain time DALLAS, Nov. 16, 2026 /PRNewswire/ -- Texas Instruments Incorporated (TI) (Nasdaq: TXN) Chairman, President and Chief Executive Officer Haviv Ilan will speak at the UBS Global Technology and AI Conference in Scottsdale, Arizona, on Tuesday, Dec. 1, at 10:15 a.m.
12 hours ago · seekingalpha.com
Septerna, Inc. (SEPN) Presents at UBS Global Biopharma Conference 2026 TranscriptSepterna, Inc. ( SEPN ) UBS Global Biopharma Conference 2026 November 16, 2026 9:00 AM EST Company Participants Jeffrey Finer - Co-Founder, CEO & Director Liz Bhatt - President & COO Conference Call Participants Alice Nettleton Presentation Alice Nettleton Good afternoon, everybody. Welcome to the next session at the UBS Global Biopharma Conference.
12 hours ago · seekingalpha.com
ADARx Pharmaceuticals, Inc. (ADRX) Presents at UBS Global Biopharma Conference 2026 TranscriptADARx Pharmaceuticals, Inc. ( ADRX ) UBS Global Biopharma Conference 2026 November 16, 2026 9:00 AM EST Company Participants Li Zhen - Co-Founder, President, CEO & Director Conference Call Participants Michael Yee - UBS Investment Bank, Research Division Presentation Michael Yee UBS Investment Bank, Research Division All right. Thank you, everyone.
13 hours ago · seekingalpha.com
Jade Biosciences, Inc. (JBIO) Presents at UBS Global Biopharma Conference 2026 TranscriptJade Biosciences, Inc. ( JBIO ) UBS Global Biopharma Conference 2026 November 16, 2026 7:00 AM EST Company Participants Tom Frohlich - President, CEO & Director Andrew King - President of Research & Development Conference Call Participants Michael Yee - UBS Investment Bank, Research Division Presentation Michael Yee UBS Investment Bank, Research Division All right. I get to say good afternoon.
3 days ago · businesswire.com
Thermo Fisher Scientific to Participate in UBS 2026 CEO Call Series on November 19, 2026WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman and chief executive officer, will participate in a fireside chat hosted by UBS on Thursday, November 19th, at 8:30 a.m. (ET). The live webcast of the presentation can be accessed via the Investors section of our website, www.thermofisher.com. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, wi.
3 days ago · fool.com
UBS Thinks Rivian Stock Can Hit $17. Is It a Buy?Rivian (RIVN -5.46%) has a potential breakthrough in its R2 SUV and UBS sees upside to $17 per share as production improves, with software revenue supporting the business. But with free cash flow deeply negative, the critical question is whether stronger vehicle margins can arrive fast enough to turn this promising growth story into a sustainable business.
4 days ago · businesswire.com
UBS Announces Redemption of Ten ETNsNEW YORK--(BUSINESS WIRE)--UBS AG announced today that it will redeem all of the outstanding securities in each of the ten series of UBS-issued exchange traded notes set forth in the following table (collectively, the “ETNs”), which are currently listed on NYSE Arca. UBS AG expects to deliver redemption notices with respect to each of the ETNs to holders of the applicable ETNs with Call Settlement Dates as set forth in the table below. With respect to BDCZ, this press release is an advance anno.
4 days ago · businesswire.com
Chime to Participate in UBS Global Technology and AI ConferenceSAN FRANCISCO--(BUSINESS WIRE)--Chime® (Nasdaq: CHYM) announced today that CEO and Co-founder Chris Britt will participate in a fireside chat at the UBS Global Technology and AI Conference in Scottsdale, AZ, on Wednesday, December 2, 2026 at 12:15 p.m. Mountain Standard Time (11:15 a.m. Pacific Time). A live webcast of the fireside chat will be accessible on Chime's Investor Relations website at investors.chime.com. A replay will be available for a limited period of time following the conferenc.
4 days ago · globenewswire.com
Royalty Pharma to present at the UBS Global Biopharma ConferenceNEW YORK, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in a fireside chat at the UBS Global Biopharma Conference on Tuesday, November 17, 2026 at 5:40 a.m. ET / 10:40 a.m. GMT.
4 days ago · fool.com
Rivian Just Earned a Buy Rating. Is Wall Street Seeing a Turning Point?Rivian was upgraded by UBS analysts to a buy. Though UBS upgraded Rivian, it left its price target the same.
Earnings
Analyst Summary
Add to Watchlist
Select watchlists to add or remove UBS